Pierce Glenn

Pierce Glenn is listed in filings as Director at Voyager Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 4, 2025, including 1 public disclosure. Recent filings connect the profile to Voyager Therapeutics, Inc. (VYGR). The current snapshot covers public activity from Jun 4, 2025. Reported amounts are shown as $78.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.